Tag Archives: MSL

Medical Affairs Consortium: Impact Measures, Globalization & Compliance

On November 6, 2014 Best Practices, LLC hosted the 1st roundtable of the 2014-2015 Medical Affairs’ Consortium. The roundtable brought together leaders from: Baxter, Crescendo, Eli Lilly, Genentech, Incyte Corporation, Jazz Pharmaceuticals, Pfizer, Santen Inc., Teva, and Upsher-Smith. Leaders from

SPECIAL: Highlights from Medical Affairs Consortium 3rd Roundtable

The Medical Affairs function is constantly changing & leaders are being presented with various obstacles and hurdles they must overcome. One of the key areas that leaders have been struggling with recently is effective thought leader management. In order to

Medical Affairs Consortium: Winning Strategies for Successful Thought Leader Management

In today’s extremely competitive and demanding healthcare landscape, pharmaceutical, biotech, and medical device organizations heavily rely on thought leaders to influence the important decisions relevant to their products. Likewise, the Medical Affairs function plays a critical role in meeting current

Best Practices in KOL Management

Thought leaders play a critical role throughout every stage of the development of new pharmaceutical products. In fact, success in the pharmaceutical sector is often linked to an organization’s ability to build, maintain and manage relationships with Key Opinion Leaders

Medical Affairs Excellence: Size of MSL Teams

As the Medical Affairs’ function continues to evolve, leaders must constantly reevaluate how they structure and staff this critical function. In order to truly enhance organizational effectiveness, leading healthcare companies must find the ideal staffing levels to run sleek and

Medical Affairs Excellence: Leadership & Value

One of the first steps in ensuring that your organization has a strong Medical Affairs function is to ensure that you have the appropriate leadership. From our Medical Affairs Consortium research & 2nd roundtable we found that the growing importance

Medical Affairs’ Excellence: Spend Allocation & Staffing

As the Medical Affairs function continues to change, so too does the way that leaders are staffing this critical function. In today’s competitive healthcare environment, there are many pressures that are affecting the spending & staffing levels of Medical Affairs

Medical Affairs: Structuring & Strong Leadership Critical for Success

Faced with shrinking sales forces, pharmaceutical companies are relying on other functions such as Medical Affairs to enhance the efforts of sales and marketing to accelerate product and business growth. Due to the increasingly important nature of the Medical Affairs

Successfully Deploying iPads to Medical Science Liaisons (MSLs)

Advances in technology have opened doors for bio-pharmaceutical companies to a gain competitive edge in the competitive healthcare market. Despite this, Medical Science Liaisons (MSLs) are still struggling to efficiently utilize iPads & effectively connect healthcare thought leaders and physicians.

Best Practices in Delivering MSL Services to Diverse Customer Groups

Biopharmaceutical & Medical Device companies often struggle with the challenge of delivering exceptional services to a diverse set of customers. On top of this, concerns about compliance and legal limitations are forcing companies to re-examine how their medical science liaisons

Role of Medical Science Liaisons Evolving to Better Navigate the New KOL Landscape

As competition for the time and attention of KOLs & hard-to-reach physicians’ increases, the need for Medical Science Liaisons (MSL) simultaneously increases.  Organizations heavily rely on MSLs in their Medical Affairs functions to build and strengthen relationships with key healthcare